Yeah we’ll see when the big studies come in with data.

Tau seems like the only remaining target for treating alzheimers so it good to see a new drug thats active in that space. Antiamyloid treatments have been ineffective. Interesting that it strenthens healthy tau structures rather than reducing overall levels of this useful/vital molecule Compared to this drug https://www.ucl.ac.uk/news/2023/apr/first-gene-silencing-drug-alzheimers-disease-shows-promise for example

Big if true